WT
RXRX icon

Whittier Trust’s Recursion Pharmaceuticals RXRX Stock Holding History

Whittier Trust’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,500
Closed -$11K – 1399
2026
Q1 		$11K Buy
3,500
+1,500
+75% +$5.8K ﹤0.01% 1108
2025
Q4 		$9.1K Buy
2,000
+800
+67% +$3.96K ﹤0.01% 1149
2025
Q3 		$6.59K Hold
1,200
– – ﹤0.01% 1189
2025
Q2 		$6.07K Hold
1,200
– – ﹤0.01% 1312
2025
Q1 		$6.35K Hold
1,200
– – ﹤0.01% 1283
2024
Q4 		$8.11K Hold
1,200
– – ﹤0.01% 1282
2024
Q3 		$7.91K Buy
+1,200
New +$8.6K ﹤0.01% 1304

Other funds holding RXRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Whittier Trust's RXRX Position: Q2 2026 in Review

Whittier Trust sold out of Recursion Pharmaceuticals (RXRX) in Q2 2026, closing a stake of 3,500 shares — an estimated $11K sold.

Whittier Trust first reported a position in RXRX in Q3 2024 and held it in 7 quarters. The position peaked at $11K in Q1 2026. 343 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

  • Whittier Trust reported no remaining Recursion Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Whittier Trust sold 3,500 Recursion Pharmaceuticals shares in Q2 2026, an estimated $11K.
  • Whittier Trust first reported a position in Recursion Pharmaceuticals in Q3 2024 and held it in 7 quarters.
  • Whittier Trust's Recursion Pharmaceuticals position peaked at $11K in Q1 2026.
  • 343 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on Whittier Trust's 13F filing for Q2 2026, filed 28 Jul 2026.